IndraLab

Statements


VCE-003.2 inhibits KCNH2. 1 / 1
| 1

reach
"In addition, VCE-003.2 administration did not inhibit hERG channel activity, suggesting a potential lack of cardiotoxicity (Additional file 3), and it was not genotoxic as assessed by AMES assays (Additional file 4)."